COVID-19

The American Lung Association (ALA) has started a $25M initiative to address the coronavirus disease 2019 (COVID-19) pandemic and other future respiratory virus pandemics.

A study based in Brazil has been halted early for safety reasons after patients with coronavirus disease 2019 taking a higher dose of chloroquine developed irregular heart rates that increased their risk of a potentially fatal heart arrhythmia.

A new test developed for the coronavirus disease 2019 (COVID-19) that uses saliva has been approved by the FDA, according to Rutgers University.

Providers with access to COVID-19 tests have reported false-negative results for some patients, raising concerns about the limitations of tests as a source of reliable information.

Although chloroquine and hydroxychloroquine have been touted as potential treatments for COVID-19, physicians in Italy have warned that the global supply may not be able to keep up with demand.

Purdue University’s College of Pharmacy is granting early graduation to 144 students to help cover a potential shortage of pharmacists during the coronavirus disease 2019 pandemic.

Troy Trygstad, PharmD, MBA, PhD, discusses the impact of COVID-19 on rural pharmacies and communities.

Suzanne Soliman, PharmD, BCMAS, discusses what the Pharmacist Moms Group is doing during COVID-19.

COA released a statement explaining that it fundamentally opposes home infusion of chemotherapy, cancer immunotherapy, and cancer treatment supportive drugs due to concerns regarding the safety of patients in such an environment.

Derek Angus, MD, MPH and his collaborators had developed a platform called REMAP-Community Acquired Pneumonia (REMAP-CAP), which was designed to find optimal treatment for severe pneumonia both in non-pandemic and pandemic settings.

Every pharmacy within the Guardian Pharmacy Service network has their own disaster contingency plan in place so that they are supported in an emergency, such as the coronavirus disease 2019 pandemic.

Top news of the week from Pharmacy Times surrounding the novel coronavirus.

A case study of a patient in Wuhan, China suggests that the immunosuppressant tocilizumab may be an effective coronavirus disease 2019 treatment for patients with multiple myeloma and other blood cancers.

Research from Wuhan, China, found that those with diabetes and high blood pressure were overrepresented among severely ill patients and those who have passed away from COVID-19.

FDA updates guidelines after man who recently recovered from COVID-19 was told that he could not donate blood for 12 months because he takes Truvada as a pre-exposure prophylaxis treatment.

The antiviral drug remdesivir was originally developed as a treatment for Ebola in 2014, but upon the surge of COVID-19, its use was investigated in treating COVID-19.

Michael Klepser, PharmD, FCCP, FIDP is not only a part of this group, but was also a potential carrier of the virus himself.

In response to the financial crisis driven by the coronavirus disease 2019 (COVID-19) pandemic, drug manufacturers are aiming to increase access to insulin products.

US Department of Health and Human Services (HHS) Secretary Alex Azar released a statement on how the authorization for pharmacists will mean easier access for patients who need COVID-19 testing.

Today we’re celebrating Lendi Muehlbauer, RPh, who works at a Rite Aid in New Jersey.

With all the factors of the COVID-19 outbreak taken into consideration, simply maintaining your current body weight and level of health and fitness is a win worth celebrating.

Coronaviruses are known to utilize the ACE2 to help facilitate entry into the host target cell.

PittCoVacc produces antibodies specific to SARS-CoV-2 at quantities thought to be sufficient for neutralizing COVID-19 within 2 weeks.

Today, we’re thanking Lusine Khachatryan, PharmD, RPh, a staff pharmacist at Vons Pharmacy in Tujunga, California.

As investigators continue to study the use of drugs such as remdesivir for the treatment of the COVID-19 pandemic, some researchers are considering drug repurposing as a temporary solution.

The American Society of Health-System Pharmacists (ASHP) is surveying members of the Section of Pharmacy Practice leaders on a bi-weekly basis to obtain the real-time status of medical supplies during the coronavirus disease 2019 (COVID-19) pandemic.

The states included are Arizona, Florida, Illinois, Kentucky, Louisiana, Tennessee, and Texas.

Our chief pharmacy editor, Troy Trygstad, PharmD, MBA, PhD, discusses various challenges and opportunities for pharmacists in rural areas during the COVID-19 pandemic.

Shivam Patel, PharmD, discusses one way pharmacist roles are changing during the COVID-19 pandemic.

Experts in Idaho are hoping that the state’s broad practice laws for pharmacists and technicians will provide a blueprint for other states looking to expand pharmacists’ capabilities.